These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 576780

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Role of inflammatory neutrophils in antitumor effects induced by intraperitoneal administration of Corynebacterium parvum in mice.
    Lichtenstein AK, Berek J, Kahle J, Zighelboim J.
    Cancer Res; 1984 Nov; 44(11):5118-23. PubMed ID: 6488171
    [Abstract] [Full Text] [Related]

  • 25. Effects of dose and schedule of immune stimulant on efficacy of combination Corynebacterium parvum-cyclophosphamide treatment for a murine mammary adenocarcinoma.
    Purnell DM, Bartlett GL, Kreider JW.
    Cancer Res; 1979 Jan; 39(1):1-5. PubMed ID: 761179
    [Abstract] [Full Text] [Related]

  • 26. Rejection of mammary adenocarcinoma cell tumors in DBA/2 mice immunocompromised by thymectomy and treatment with antithymocyte serum.
    Likhite VV.
    J Immunol; 1975 Jun; 114(6):1736-42. PubMed ID: 1092759
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The immunological activities of components isolated from Corynebacterium parvum in mice injected with polyoma tumor cells.
    Tomecki J, Mara M.
    Neoplasma; 1987 Jun; 34(1):15-22. PubMed ID: 3031518
    [Abstract] [Full Text] [Related]

  • 30. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. IX. Macrophage content of tumors in mice.
    Gebhardt MC, Fisher B.
    J Natl Cancer Inst; 1979 Apr; 62(4):1035-41. PubMed ID: 285276
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum.
    Chen L, McGowan P, Ashe S, Johnston JV, Hellström I, Hellström KE.
    Cancer Res; 1994 Oct 15; 54(20):5420-3. PubMed ID: 7522958
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Immunotherapy of an established rat mammary adenocarcinoma (13762A) with intratumor injection of Corynebacterium parvum.
    Kreider JW, Bartlett GL, Purnell DM, Webb S.
    Cancer Res; 1978 Mar 15; 38(3):689-92. PubMed ID: 626972
    [Abstract] [Full Text] [Related]

  • 35. Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells.
    Krahenbuhl JL, Lambert LH, Remington JS.
    Immunology; 1976 Dec 15; 31(6):837-46. PubMed ID: 992714
    [Abstract] [Full Text] [Related]

  • 36. Further studies on the enhancement of the antibody response in vitro by C. parvum.
    Slijivíc VS, Brown CA, Watson SR.
    Dev Biol Stand; 1976 Dec 15; 38():147-52. PubMed ID: 608502
    [Abstract] [Full Text] [Related]

  • 37. Enhancement by Corynebacterium parvum of the normal and tumor tissue response to hyperthermia.
    Urano M, Overgaard M, Suit H, Dunn P, Sedlacek R.
    Cancer Res; 1978 Mar 15; 38(3):862-4. PubMed ID: 626985
    [Abstract] [Full Text] [Related]

  • 38. Effect of Corynebacterium parvum on the class and subclass of antibody produced in the response of different strains of mice to sheep erythrocytes.
    Warr GW, James K.
    Immunology; 1975 Mar 15; 28(3):431-42. PubMed ID: 1092609
    [Abstract] [Full Text] [Related]

  • 39. In vivo antitumor effects of monoclonal antibodies with different immunoglobulin classes.
    Seto M, Takahashi T, Nakamura S, Matsudaira Y, Nishizuka Y.
    Cancer Res; 1983 Oct 15; 43(10):4768-73. PubMed ID: 6192909
    [Abstract] [Full Text] [Related]

  • 40. Fc receptor-bearing and phagocytic cells in syngeneic tumours of C. parvum- and carrageenan-treated mice.
    Thomson AW, Cruickshank N, Fowler EF.
    Br J Cancer; 1979 May 15; 39(5):598-602. PubMed ID: 486317
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.